Recent studies have shown that the high infiltration of Tregs with elevated TGFβ1 expression in CRC tissues is not only closely associated with poor patient prognosis but also linked to increased resistance to PD‐1/PD‐L1 immune checkpoint inhibitors [28, 29]. The gene discussed is PDCD1; the disease is colorectal carcinoma.